Hikma Pharmaceuticals PLC

H5P

Company Profile

  • Business description

    Hikma Pharmaceuticals PLC is engaged in developing, manufacturing, and marketing a broad range of generic, branded and non-branded, in-licensed pharmaceutical products. The firm operates in three segments: injectables, generics, and branded. The majority of the revenue for the company is generated from its injectables segment under which it supplies hospitals across markets with generic injectable products, supported by its manufacturing facilities. Geographically, North America is the company's key revenue generating market followed by Middle East and North Africa, United Kingdom, Europe and the rest of the world.

  • Contact

    1 New Burlington Place
    LondonW1S 2HR
    GBR

    T: +44 2073992760

    E: [email protected]

    https://www.hikma.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Drug Manufacturers - Specialty & Generic

    Fiscal Year End

    31 December 2026

    Employees

    9,500

Stocks News & Analysis

stocks

Navigating the ASX dividend landscape in 2026

Dividend yields are well below the 10-year average. Here’s how to navigate lower yields in 2026.
stocks

Meta stock has struggled amid AI spending concerns. Is it a buy?

Meta stock has lost ground as investors raise concern over capital expenditures and risky AI strategies.
stocks

Netflix Earnings: Strong, as expected; 2026 guidance confirms decelerating growth

We think Netflix stock is moderately overvalued.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries9,108.6016.200.18%
CAC 408,069.176.590.08%
DAX 4024,560.98142.14-0.58%
Dow JONES (US)48,737.63249.040.51%
FTSE 10010,138.0911.310.11%
HKSE26,585.0697.550.37%
NASDAQ22,988.1533.830.15%
Nikkei 22552,774.64216.46-0.41%
NZX 50 Index13,417.17156.76-1.15%
S&P 5006,824.1327.270.40%
S&P/ASX 2008,782.9014.000.16%
SSE Composite Index4,116.943.290.08%

Market Movers